Home > Insider Trading > Filing (0001225208-11-014524)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1099800	Edwards Lifesciences Corp	EW	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	364316614

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1440661	C Paul Redmond	One Edwards Way Irvine CA 92614	Cvp, Global Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-05-13	17,200	$27.77	41,983	No	4	M	Direct
Common Stock	Acquisiton	2011-05-13	15,000	$31.47	56,983	No	4	M	Direct
Common Stock	Acquisiton	2011-05-13	11,400	$50.96	68,383	No	4	M	Direct
Common Stock	Disposition	2011-05-13	14,915	$89.28	53,468	No	4	S	Direct
Common Stock	Disposition	2011-05-13	28,685	$88.31	24,783	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Acquire)	Acquisiton	2011-05-12	27,200	$0.00	27,200	$89.23
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2011-05-13	15,000	$0.00	15,000	$31.47
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2011-05-13	17,200	$0.00	17,200	$27.77
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2011-05-13	11,400	$0.00	11,400	$50.96

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
27,200	2012-05-12	2018-05-11	No	4	A	Direct
30,000	2010-05-07	2016-05-06	No	4	M	Direct
34,400	2009-05-08	2015-05-07	No	4	M	Direct
34,200	2011-05-13	2017-05-12	No	4	M	Direct

Footnotes

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
This transaction was executed in multiple trades at prices ranging from $89.03 to $89.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $88.00 to $88.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on May 12, 2011 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and becomes exercisable commencing one year after the grant date in four equal annual installments.